Chronic pain is common and debilitating, and its treatment continues to present challenges to the medical community.

Sonya Collins

There is an expanding variety of home testing and monitoring kits available for patients interested in preventative care, detecting the presence or absence of a medical or physiologic condition, and monitoring therapy or results of a wellness routine.

A federal judge in Ohio who oversees the National Prescription Opiate Litigation (NPOL) has recently issued a ruling with significant implications for pharmacists and pharmacies.

David B. Brushwood, BSPharm, JD

Mental health disorders are common, complex to diagnose and treat, and costly to manage. They are also associated with a high risk of morbidity and mortality. Common disorders such as depression and anxiety are among the leading causes of disease burden globally. WHO reports that anxiety disorders affect over 260 million people.

Adrijana Kekic, PharmD, CTLC

Topical analgesics are often used to relieve pain associated with aches and pains in muscles and joints, such as backaches, arthritis, strains, bruises, and sprains.

Mary Warner

Updates from FDA

Everyone has gas; producing and passing gas is a normal part of the digestion process.

Patients suffering from joint and muscle pain often turn to complementary and alternative medicine for relief. Arnica has a long history in treating numerous medical conditions such as insect bites, bruises, scars, fever, apprehension, sciatica, and rash, but it’s primarily recommended for inflammation, arthritis, muscle aches, and stiffness. So, what does the science say?

Mickie Cathers

In January of this year, FDA approved Brenzavvy (bexagliflozin—TheracosBio), a sodium-glucose cotransporter 2 (SGLT-2) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2D). Brenzavvy is the fifth SGLT-2 inhibitor to become FDA approved.

Lauren Howell, PharmD

“Artificial intelligence (AI) is going to seriously disrupt medical practice over the next 5 to 10 years,” said Steven Charlap, MD, MBA, founder and CEO of SOAP Health, an AI-powered artificial digital human assistant that identifies, verifies, and simplifies patient-reported data collection, risk assessment, and electronic delivery.

Clarissa Chan, PharmD